<!DOCTYPE html>
<html lang="en">
    <style>
        /* Basic styles for the button */
        #startButton {
            padding: 10px 20px;
            background-color: #007BFF;
            color: white;
            border: none;
            border-radius: 5px;
            cursor: pointer;
            font-size: 16px;
            margin: auto;
            transition: background-color 0.3s ease, transform 0.2s ease;
        }

        #startButton:hover {
            background-color: #0056b3; /* Darker blue on hover */
            transform: scale(1.05); /* Slightly increase size on hover */
        }

        #startButton:disabled {
            background-color: #ccc; /* Gray when disabled */
            cursor: not-allowed; /* Change cursor when disabled */
        }

        /* Optional styles for the SVG */
        svg {
            margin-top: 20px;
        }
		.label {
            pointer-events: none; /* Prevents interaction with the label */
        }
    </style>
    <script src="h2cm.js"></script>
</head>
<body onload="lodd();">
<script>
window.onload = function(){
    mermaid.initialize({
        theme: 'forest',
		flowchart: { useMaxWidth: true, htmlLabels: true},securityLevel: 'loose'
    });
}

// theme: https://github.com/knsv/mermaid/tree/master/src/themes
// default, forest, dark and neutral
</script>
<script type="text/javascript" src="mermaid.min.js"></script>
<button id="startButton">Start Highlighter</button>

<div style="width:100%;display:none;">
graph TD;
    A[Anemia] -->|Iron deficiency| B[Etiology];
    B -->|Dietary insufficiency| C[Eating habits];
    B -->|Blood loss| D[Hemorrhage];
    B -->|Malabsorption| E[Gastrointestinal disorders];
    B -->|Increased demand| F[Pregnancy, growth];
    B -->|Other causes| G[Chronic diseases];
    C -->|Low iron intake| H[Vegetarian diet];
    C -->|Poor absorption| I[Gastric surgery];
    D -->|Acute| J[Trauma];
    D -->|Chronic| K[Peptic ulcer];
    E -->|Celiac disease| L[Small intestine];
    E -->|Inflammatory bowel disease| M[Intestinal inflammation];
    F -->|Physiological| N[Pregnancy];
    F -->|Pathological| O[Puberty];
    G -->|Renal failure| P[Chronic kidney disease];
    G -->|Chronic infection| Q[Inflammatory diseases];
    G -->|Malignancy| R[Cancer];
    G -->|Other chronic diseases| S[Heart failure];
    A -->|Compensatory mechanisms| T[Red blood cell production];
    T -->|Bone marrow response| U[Increased erythropoiesis];
    U -->|Microcytic hypochromic RBCs| V[Peripheral blood smear];
    V -->|Characteristic findings| W[Low MCV, MCH];
    W -->|Anisocytosis, poikilocytosis| X[Peripheral smear];
    X -->|Hypochromic, microcytic cells| Y[Iron deficiency morphology];
    Y -->|Ringed sideroblasts| Z[Prussian blue staining];
    Z -->|Confirmatory diagnosis| AA[Staining];
    A -->|Clinical manifestation| BB[Symptoms];
    BB -->|Mild to moderate| CC[Fatigue, weakness, pallor, irritability, cognitive impairment, headache, decreased exercise tolerance, pica : craving for non-food items];
    BB -->|Severe| DD[Dyspnea, tachycardia, angina, palpitations, syncope, orthostatic hypotension, leg cramps, angina, systolic murmur];
    A -->|Physical examination| EE[Signs];
    EE -->|Pallor| FF[Conjunctiva, palms, nail beds, mucous membranes];
    EE -->|Koilonychia| GG[Spoon-shaped nails];
    EE -->|Angular cheilitis| HH[Inflammation at corners of mouth];
    EE -->|Glossitis| II[Inflammation of tongue];
    EE -->|Brittle nails| JJ[Fragile nails, longitudinal ridges];
    A -->|Diagnostic tests| KK[Laboratory tests];
    KK -->|CBC| LL[Low Hb, Low MCV, Low MCH, Low RBC count, RDW increased];
    KK -->|Peripheral smear| MM[Microcytic, hypochromic cells, Target cells, Pencil cells, Tear drop cells];
    KK -->|Iron studies| NN[Low serum iron, Low ferritin, High TIBC, Low transferrin saturation];
    NN -->|Confirmation| OO[Ferritin levels];
    OO -->|Low ferritin| PP[Iron deficiency confirmed];
    A -->|Underlying cause| QQ[Treat underlying disorder];
    QQ -->|GI evaluation| RR[Endoscopy, Colonoscopy];
    QQ -->|Hemostasis| SS[Surgical intervention, Medication];
    QQ -->|Management| TT[Address chronic disease, Treat infections, Optimize nutrition];
    A -->|Treatment| UU[Treatment];
    UU -->|Iron supplementation| VV[Oral, Intravenous];
    VV -->|Oral| WW[Ferrous sulfate, Ferrous gluconate, Ferrous fumarate, Polysaccharide iron complex];
    VV -->|Intravenous| XX[Iron dextran, Iron sucrose, Ferric carboxymaltose];
    UU -->|Dietary changes| YY[Increase iron-rich foods, Vitamin C supplementation, Avoid tea/coffee with meals];
    UU -->|Blood transfusion| ZZ[Severe cases, Symptomatic patients];
    ZZ -->|Complications| AAA[Iron overload, Transfusion reactions];
    AAA -->|Monitor| BBB[Ferritin levels, Iron studies, Liver function tests];
</div>
<div style="width:100%;display:none;">
graph TB
  A-->B
  B-->C
  B-->D
  B-->E
  B-->F
  B-->G
  B-->H
  B-->I
  B-->J
  B-->K
  B-->L
  B-->M
</div>

<div class="mermaid" style="width:100%;">
flowchart TB
    A@{ img: "i/mol_0.png", label: "L-Phenylalanine", pos: "t", w: 200, h: 200, constraint: "off" }
    B@{ img: "i/mol_1.png", label: "L-Tyrosine", pos: "t", w: 200, h: 200, constraint: "off" }
    C@{ img: "i/mol_2.png", label: "L-DOPA <br>(3,4_dihydroxyphenylalanine)", pos: "t", w: 200, h: 200, constraint: "off" }
    D@{ img: "i/mol_3.png", label: "L-Dopamine", pos: "t", w: 200, h: 200, constraint: "off" }
    E@{ img: "i/mol_4.png", label: "L-Noradrenaline", pos: "t", w: 200, h: 200, constraint: "off" }
    F@{ img: "i/mol_5.png", label: "L-Noradrenaline", pos: "t", w: 200, h: 200, constraint: "off" }
	A -->|"Phenylalanine Hydroxylase <br>(in liver)"| B
	B -->|"Tyrosine Hydroxylase <br>(cytosolic enzyme)"| C
	C -->|"Dopa-Decarboxylase <br>(cytosolic enzyme)"| D
	D -->|"Dopamine-β-Hydroxylase <br>(in synaptic vesicles)"| E
	E -->|"Phenylethanolamine-N-Methyltransferase <br>(in adrenal medulla)"| F
</div>

<div class="mermaid" style="width:100%;">
flowchart TD
    A[ADRENALINE] -->|COMT| C[Metanephrine]
    A -->|MAO| B("DOMA<br>(Di-hydroxy Mandelic acid)")
    B -->|COMT| D["VMA (3-methoxy-4-hydroxy-mandelic acid)"]
    C ---->|MAO| D
    E[NORADRENALINE] -->|MAO| B
    E -->|COMT| F[Normetanephrine]
    F ---->|MAO| D
    B -->|MAO| G["MOPED<br>(3-methoxy-4-hydroxy-phenylethylglycol)"]
</div>

<div class="mermaid" style="width:100%;">
flowchart TD
    H[DOPAMINE] -->|MAO| I["DOPAC (3,4-dihydroxyphenyl acetic acid)"]
    H -->|COMT| J[Methoxytyramine]
    I -->|COMT| K["HVA (Homovanillic acid)"]
</div>

<div id="ccfp" class="mermaid" style="width:100%;">
flowchart TB
    A3[Pathogenesis of <br>Congestive Cardiac Failure]
    A3 --> A0[Acute Cardiac Failure] --> A[Sudden onset LV dysfunction] --> B[Acute decrease in CO]
    A3 ---> A2[Chronic Cardiac Failure] --> D[Gradual LV dysfunction] --> E[Gradual decrease in CO]
    E --> F[Compensatory mechanisms]
    F ----> Compensation
    F --> H[Failure] --> leads
    B ----> leads
    subgraph Compensation
    direction TB
    M[Compensation by]
    M --> N[⇧ Catecholamines]
    M --> O[RAS activation]
    N --> P[⇧ Heart Contraction]
    N --> P2["⇧ Heart Rate"]
    N --> R[⇧ Vasoconstriction]
    O --> T[⇧ Vasoconstriction]
    O --> U[⇧ Na + H2O Retention]
    end
    subgraph Treatment["Treatment_::_Opposition"]
	R --> X1[VD] --> W2[Nitrates]
    X1 --> Z2[Nitroprusside]
    T --> S[ACEIs , ARBs]
    P2 --> Q
    P --> Q[B blockers, Ivabridine]
    U --> S
	end
	subgraph leads[leads to]
    direction TB
    C3[Pulmonary edema] --> C[Treated by]
    C --> V[Loop diuretics]
    C --> X[Vasodilators]
    X --> W[Nitrates]
    C --> Y[BNP analogs]
    X --> Z[Nitroprusside]
	B2[Low cardiac output] --> |only in Acute| C2[Treated by] --> I4[Inotropes]
    end
	B --> B2
	Treatment ===> in[Inhibits]
	in ==> |"Thus<br>Decrease"| L[Mortality]
	in ==> K[⇧ Cardiac remodelling]
	Compensation ----> |Causes| J1[⇧ Increased stress on myocardium] --> J[causes hypertrophy]
    J --> K
    K --> L
</div>

<div class="mermaid" style="width:100%;">
flowchart TB
    A[Acute CHF] --> B[Low cardiac output]
    A --> C[Pulmonary edema]
    B --> D[Start inotropes<br>First choice: Dobutamine<br>Alternatives: Dopamine/Milrinone/Levosimendan]
    C --> E[Start loop diuretics]
    E --> F[Morphine]
    F -- Not responding --> G[Vasodilators]
    G -- Not responding --> H["Nesiritide(BNP)"]
</div>

<div class="mermaid" style="width:100%;">
flowchart TB
    A[Chronic CHF] --> B[ACEI/ARB]
    B --> C[Beta blockers]
    C -- Not responding --> D[Aldosterone antagonists]
    D -- Not responding --> E["Ivabridine<br>(inhibit funny)"]
    E -- Not responding --> F["Isosorbide dinitrate (ISDN) + Hydralazine"]
    F -- Not responding<br>(finally) --> G[Digoxin]
</div>

<div class="mermaid" style="width:100%;">
flowchart TB
    A[β blocker toxicity] --> B[Decreased cyc AMP]
    A --> C[AV Block]
    A --> D[Hypotension]
    B --> E[Glucagon Antidote of choice]
    C --> F[Atropine]
    D --> G[Isoproteronol]
</div>

<div class="mermaid" style="width:100%;">
flowchart TB
  subgraph ag[Age groups]
   direction TB
    A[Age < 55 years] --> B[ACEI/ARB]
    C[Age ≥ 55 years] --> D[CCB]
  end
    ag -->|Inadequate control after 1 month| F[ACEI/ARB + CCB]
    F -->|Inadequate control after 1 month| H[ACEI/ARB + CCB + Thiazide]
    H -->|Inadequate control after 1 month| J[Resistant hypertension]
    J --> K[ACEI/ARB + CCB + Thiazide + Spironolactone]
</div>

<div class="mermaid" style="width:100%;">
flowchart LR
    A[Classification] --> B[Non-cardioselective]
    B --> C[Propranolol, timolol, sotalol]
    A --> D[Cardioselective]
    D --> E[Atenolol, metoprolol, esmolol, betaxolol]
    A --> F[Partial agonist]
    F --> G[Pindolol, oxprenolol]
    A --> H[With additional α blocking property]
    H --> I[Labetalol, carvedilol]
    A --> J[With additional β2 agonistic property]
    J --> K[Celiprolol]
    A --> L[With additional antioxidant property]
    L --> M[Carvedilol]
</div>

<div class="mermaid" style="width:100%;">
flowchart LR
    A[Pharmacological actions] --> B["1: CVS"]
    B --> C["↓ HR, FOC, CO, BP"]
    C --> D[Hence ↑ cardiac work]
    B --> E[↓ Myocardial O₂ requirement]
    E --> F[Hence ↑ cardiac work]
    B --> G[Effect more significant in presence of high sympathetic tone than in normal individuals]
    B --> H[Delays AV conduction]
    B --> I[↑ Exercise tolerance in angina pectoris patients]
    B --> J[Prevents exercise-induced ↑ in HR and FOC]
    B --> K["Possesses membrane stabilization property (like quinidine) at high doses"]
    K --> L[Hence causes direct myocardial depression]
    A --> M["2: Respiratory system"]
    M --> N[Causes bronchoconstriction due to β2 blockade]
    N --> O[Thus precipitates acute attacks in asthma]
    A --> P["3: Eye"]
    P --> Q[↓ IOP, as ↓ aqueous humor secretion from ciliary body]
    A --> R["4: Metabolism"]
    R --> S[Blocks lipolysis]
    R --> T["Blocks glycogenolysis (β2 action)"]
    T --> U[Hence nonselective β blockers interfere with recovery of hypoglycemia in diabetics]
    R --> V["↑ Triglycerides, ↓ HDL"]
</div>

<div class="mermaid" style="width:100%;">
flowchart LR
    A[Uses] --> B1["1: Hypertension"]
    B1 --> C1[Mild to moderate]
    B1 --> D1[Alone or in combination with other antihypertensives]
    A --> E1["2: Angina pectoris"]
    E1 --> F1[Prophylaxis of exertional angina]
    E1 --> G1[They ↓ frequency and severity of attacks]
    E1 --> H1[They ↓ cardiac work and O₂ consumption]
    A --> I1["3: Arrhythmias"]
    I1 --> J1["Ventricular/supraventricular arrhythmias"]
    J1 --> K1[Sotalol is preferred]
    A --> L1["4: Myocardial infarction"]
    L1 --> M1[IV β blocker ↓ size of infarct]
    L1 --> N1[Long-term administration ↑ survival]
    A --> B["5: Congestive cardiac failure (CCF)"]
    B --> C[Earlier CCF was a contraindication]
    B --> D[Recent studies demonstrate their benefit if used judiciously in select patients]
    D --> E[Hemodynamically stable]
    B --> F[↓ Sudden death]
    B --> G[↑ Survival]
    A --> H["6: Obstructive cardiomyopathy"]
    B --> I[Inhibits sympathetic stimulation]
    B --> J[Prevents cardiac remodeling]
    J --> K[This is detrimental to heart]
    A --> L["7: Pheochromocytoma"]
    L --> M[Along with α blockers]
    L --> N[↓ Palpitations, tremors hence provides only symptomatic relief]
    A --> O["8: Thyrotoxicosis"]
    O --> P[Beneficial even in thyrotoxic crisis or thyroid storm]
    O --> Q[Prevents peripheral T4 → T3 conversion]
    A --> R["9: Glaucoma"]
    R --> S[Topical timolol]
    R --> T[Open angle and narrow angle glaucoma]
    R --> U[First-line treatment]
    A --> V["10: Migraine prophylaxis"]
    V --> W[↓ Frequency and severity of attacks]
    A --> X["11: Anxiety"]
    X --> Y["Acute panic symptoms of public speaking/ examination"]
    X --> Z["↓ Sympathetic stimulation e:g:, tremor, palpitations"]
</div>

<div class="mermaid" style="width:100%;">
flowchart LR
    A[Adverse reactions] --> B["1: Bradycardia"]
    B --> C[In heart block in patients with conduction defects]
    B --> D["In patients with arrhythmia (bradyarrhythmias)"]
    A --> E["2: CCF"]
    E --> F[In patients with reduced cardiac function, sympathetic activity maintains cardiac function]
    F --> G["However, β blockers ↓ this, thus aggravate cardiac failure"]
    A --> H["3: Cold extremities"]
    H --> I[Esp: in patients with peripheral vascular disease]
    A --> J["4: Acute bronchial asthma"]
    J --> K[Due to blockade of β2 receptors; hence there is bronchoconstriction]
    K --> L["Esp: with nonselective β blockers (propranolol)"]
    A --> M["5: CNS"]
    M --> N["Insomnia, depression, rarely hallucinations"]
    A --> O["6: Fatigue"]
    O --> P["Due to ↓ CO, there is ↓ in blood flow to skeletal muscles"]
    A --> Q["7: Metabolic side effects"]
    Q --> R["↑ Triglycerides, ↓ HDL"]
    Q --> S[Dangerous side effect]
    A --> T["8: Rebound hypertension"]
    T --> U[On abrupt withdrawal after long-term use]
    T --> V[Dangerous side effect]
    A --> W["9: Rebound angina"]
    W --> X[On abrupt withdrawal after long-term use]
    W --> Y[Both due to upregulation of β receptors]
    A --> Z["10: Dizziness"]
    Z --> AA[Hence β blockers should be gradually tapered]
</div>

<div class="mermaid" style="width:100%;">
flowchart LR
    A[Contraindications] --> B["1: Bradycardia"]
    A --> C["2: Heart Block"]
    A --> D["3: Bronchial asthma and COPD"]
    A --> E["4: Diabetes mellitus"]
    A --> F["5: Congestive cardiac failure (judicious use in select patients)"]
</div>

<div class="mermaid" style="width:100%;">
flowchart LR
    A[Cardioselective β blockers] --> B["e:g:, Atenolol, metoprolol, esmolol"]
    B --> C["Selective β1 blockade, insignificant β2 blockade"]
    C --> D[Hence there is minimal bronchoconstriction]
    B --> E["Safer in diabetics, as there is less inhibition of glycogenolysis"]
    B --> F[Lesser impairment of exercise performance]
    B --> G[Reduced chances of peripheral vascular disease]
</div>

<div class="mermaid" style="width:100%;">
flowchart LR
    A2[Partial agonists] --> B2["e:g:, Pindolol, oxprenolol"]
    B2 --> C2[Possess intrinsic sympathomimetic activity]
    C2 --> D2[Hence there is minimal bradycardia and cardiac depression]
    C2 --> E2[Thus they are preferred in patients with bradycardia and cardiac function]
</div>

<div class="mermaid" style="width:100%;">
flowchart LR
    A[Some individual β blockers] --> B[Acebutalol]
    B --> C[Possesses partial agonist activity]
    B --> D["Used in hypertension, arrhythmias"]
    A --> E[Celiprolol]
    E --> F[Possesses additional β2 agonist activity]
    E --> G[Hence safe in asthmatics]
    A --> H[Timolol]
    H --> I[Nonselective β blocker]
    H --> J[Short-acting]
    H --> K[Eye drops used in glaucoma]
    A --> L[Labetalol]
    L --> M["Blocks β1, β2, and α1 receptors"]
    M --> N[Hence acts as both α and β blocker]
    L --> O[Causes vasodilation]
    O --> P[↑ Blood flow to extremities]
    P --> Q[So there are no cold extremities and peripheral vascular disease chances]
    L --> R[It has both α1 and β blockade activity]
    A --> S[Carvedilol]
    S --> T["β1, β2, and α1 blockade activity"]
    S --> U[Additional antioxidant property]
    U --> V[Thus beneficial in patients with hypertension and CCF]
</div>

<script>

// Function to handle mouseover
function handleMouseOver(event) {
    event.target.style.fill = 'yellow';
}

// Function to handle mouseout
function handleMouseOut(event) {
    event.target.style.fill = null; // Reset to original color
}

// Function to start listening to events
function startListening() {
    const nodeElements = document.querySelectorAll('.node');

    nodeElements.forEach(node => {
        const originalColor = node.getAttribute('fill');
        node.addEventListener('mouseover', handleMouseOver);
        node.addEventListener('mouseout', handleMouseOut);
    });

    document.getElementById('startButton').disabled = true; // Disable button after activation
}

// Attach the click event to the button
document.getElementById('startButton').addEventListener('click', startListening);

</script>
</body>
</html>
